Springfield City Group joins forces with UQ to improve health and wellbeing

Australia’s biggest master-planned community could soon become one of our healthiest.

Curavit launches HEOR services for digital therapeutic trials – Pharmaceutical Technology

Inclusion of HEOR in clinical trials can give medicine manufacturers insight into product value and market potential. Image credit: Shutterstock/Anton Vierietin. Virtual contract research organisation

November 1, 2023

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement.

May 21, 2024

Bristol Myers to buy cancer player Mirati for more than $4.8 billion

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that

October 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.